Ocular Therapeutix, Inc. (OCUL)
9.675
-0.04
(-0.36%)
USD |
NASDAQ |
May 07, 15:45
Ocular Therapeutix SG&A Expense (TTM) : 87.80M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EyePoint, Inc. | 37.79M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Vertex Pharmaceuticals, Inc. | 1.357B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Rhythm Pharmaceuticals, Inc. | 155.85M |